NovoCure Ltd. (NVCR)
17.62
+0.86
(+5.13%)
USD |
NASDAQ |
Aug 25, 16:00
17.61
-0.01
(-0.06%)
After-Hours: 19:59
NovoCure Enterprise Value : 1.835B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.835B |
| August 24, 2026 | 1.735B |
| August 21, 2026 | 1.774B |
| August 20, 2026 | 1.852B |
| August 19, 2026 | 1.902B |
| August 18, 2026 | 1.790B |
| August 17, 2026 | 1.824B |
| August 14, 2026 | 1.757B |
| August 13, 2026 | 1.807B |
| August 12, 2026 | 1.831B |
| August 11, 2026 | 1.839B |
| August 10, 2026 | 1.799B |
| August 07, 2026 | 1.691B |
| August 06, 2026 | 1.610B |
| August 05, 2026 | 1.652B |
| August 04, 2026 | 1.677B |
| August 03, 2026 | 1.567B |
| July 31, 2026 | 1.511B |
| July 30, 2026 | 1.556B |
| July 29, 2026 | 1.553B |
| July 28, 2026 | 1.682B |
| July 27, 2026 | 1.766B |
| July 24, 2026 | 1.838B |
| July 23, 2026 | 2.111B |
| July 22, 2026 | 1.596B |
| Date | Value |
|---|---|
| July 21, 2026 | 1.646B |
| July 20, 2026 | 1.639B |
| July 17, 2026 | 1.637B |
| July 16, 2026 | 1.695B |
| July 15, 2026 | 1.650B |
| July 14, 2026 | 1.594B |
| July 13, 2026 | 1.657B |
| July 10, 2026 | 1.681B |
| July 09, 2026 | 1.796B |
| July 08, 2026 | 1.806B |
| July 07, 2026 | 1.846B |
| July 06, 2026 | 1.800B |
| July 02, 2026 | 1.786B |
| July 01, 2026 | 1.620B |
| June 30, 2026 | 1.547B |
| June 29, 2026 | 1.586B |
| June 26, 2026 | 1.580B |
| June 25, 2026 | 1.536B |
| June 24, 2026 | 1.498B |
| June 23, 2026 | 1.430B |
| June 22, 2026 | 1.369B |
| June 18, 2026 | 1.447B |
| June 17, 2026 | 1.861B |
| June 16, 2026 | 1.819B |
| June 15, 2026 | 1.832B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LivaNova Plc | 4.207B |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Accuray, Inc. | 174.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 183.58M |
| Total Expenses (Quarterly) | 199.24M |
| EPS Diluted (Quarterly) | -0.135 |
| Gross Profit Margin (Quarterly) | 77.61% |
| Profit Margin (Quarterly) | -8.53% |
| Earnings Yield | -7.43% |
| Normalized Earnings Yield | -7.432 |